ozempic semaglutide patent expiration date Novo Nordisk to Launch in India Before Expiry in March 2026 semaglutide patent novo nordisk The
Description
The medication is administered once weekly via subcutaneous injection and is indicated for adults with type 2 diabetes to improve glycaemic control
Consequently, quality can vary between manufacturers
Rapid weight loss, dehydration, and changes in fat metabolism can temporarily stress the liver in some cases
Canal de Velasco LM, Gonzlez Flores JE
Semaglutide is a medication that mimics the natural GLP-1 hormone
Discuss your specific fracture risk with your licensed healthcare provider before and during any GLP-1 treatment
